Blue Horseshoe Stocks

Blue Horseshoe Stocks: KOOL, TIF Recaps & More

Endocyte, Inc. ECYT

We initially took notice of ECYT on Monday morning just as the company announced it had completed a worldwide license for its prostate cancer treatment now moving into Phase-3 development.

The stock made a solid 130% rip from 1.63 to 3.75 that morning, but it was only just getting started. Yesterday morning the stock ran hard once again, reaching its peak at a new annual high of 6.55. That puts the total on our two-day observed increased of 302% while volume over the same period has been literally hundreds of times greater than the monthly average prior to Monday’s bombshell PR.

Tiffany & Co. TIF – Options Update

As we were just mentioning yesterday morning, we’ve been tracking the TIF 10/20 $92-93 Calls since the morning of September 28th. TIF stock has maintained its gradual ascent since that time, and with that, we’ve seen the potential gains made off of our ideas grow along with it.

The following ranges represent the lows from the 28th to the highs achieved during yesterday’s session:

$92 Calls – Range: 1.00-2.20 – Max Gain: 120%
$92.50 Calls – Range: .85-2.19 – Max Gain: 158%.
$93 Calls – Range: .83-2.15 – Max Gain: 159%

Cesca Therapeutics Inc. KOOL

After including KOOL in yesterday morning’s watchlist, we watched as the stock made a very nice intraday run on the chart with the help of some positive news.

The U.S. Patent and Trademark Office issued a Notice of Allowance on the company’s patent application for its proprietary method for separating target cells from blood, marrow, and other sources.

That prompted a solid boost from 3.96 to 6.44 on the day, marking an intraday push of 63% which was accompanied by the trading of 223X more shares than the monthly average!

Extended Watchlist:
CATB, RGSE, CAPR, ATNM, VKTX, MNKD, BIOP, HTBX

Blue Horseshoe Stocks: ECYT Recap & More

Endocyte, Inc. ECYT

We took notice of ECYT yesterday morning during our routine premarket scan, and due to some abnormal activity, we decided to include it in the daily watchlist.

It turned out to be a splendid idea, with the stock ultimately recording a hugely bullish session. ECYT traded from its low of 1.63 just following the open, to its high of 3.75 just prior to the close. It worked out to a single-session rip of 130% and it came on over 180X the monthly average volume. The stock has also hit a new high of 6.07 in the premarket this morning, pushing our observed move in less than 24 hours to a whopping 272%

It was especially impressive because of the timing, which couldn’t have been any better. Prior to yesterday’s session the stock was stagnating for several months. The move was catalyzed primarily by the announcement of the completion of a worldwide license on the company’s prostate cancer treatment, which will be moving on to Phase III development. (>>View PR)

Rigel Pharmaceuticals, Inc. RIGL

Speaking of solidly-timed calls on pharma plays, we also caught RIGL and included it in yesterday’s premarket report. It didn’t see the type of move that the previously mentioned stock, but got off to a respectable start.

RIGL traded in a range from 2.85-3.42, a modest rise of 20%, but did so on nearly 17X the monthly average volume, and closed near its high of day. We’ll continue to observe this play to see if it can establish a sustained uptrend.

Capricor Therapeutics, Inc. CAPR

We were just updating our readers yesterday morning on the moves CAPR had made since we had alerted it onSeptember 20th from its low of 1.80.

What followed was another nice session for the stock, which ran to a new high of 4.25; a total increase of 136% in a span of just eight trading days.

Tiffany & Co. TIF – Options Update

We also want to quickly update readers on our TIF options ideas that we submitted on the morning of September 28th, the TIF 10/20 $92-93 Calls. The stock has been in a continuous bullish pattern since then, and those calls made some pretty nice gains in the process.

$92 Calls – Range: 1.00-2.13 – Max Gain: 113%
$92.50 Calls – Range: .85-1.74 – Max Gain: 105%.
$93 Calls – Range: .83-1.88 – Max Gain: 127%

Extended Watchlist:
ETRM, VICL, DMPI, TA, KOOL, CATB

Blue Horseshoe Stocks: CAPR, VYGR, HMNY Recaps & More

Recent Big Winners

We have a large group of updates on previously called plays that we wanted to briefly swing back around and report performance information on this morning:

Voyager Therapeutics, Inc. VYGR – We alerted on VYGR on the 6th of September, witnessing a low of 12.33 and after finishing the rest of the month on a bullish streak, Friday brought a new high of 22.28. That’s a three week swing of 81%, which is fantastic for a stock in this price range.
______

Capricor Therapeutics, Inc. CAPR – We signaled our interest in CAPR later on in September,on the 20th. The following day we observed a low of 1.80, and like the above-mentioned play, it never looked back. Friday’s new high of 3.05, represented a 69% increase in just over a week’s time.
______

Helios and Matheson Analytics Inc. HMNY – We’ve discussed this one quite a bit recently, also beginning on September 20th. That morning we saw a low of 5.469, and once again, it has been nothing but bullish moves ever since. On Friday the stock hit 14.17, marking a fantastic move of 159% in a little over a week.

Blackberry Ltd. BBRY – Options Recap

We also wanted to provide the final figures on the BBRY options we signaled in Thursday’s premarket report, the BBRY Weekly $9.50 & $10 Calls. Friday’s session brought new highs for both sets.

The final intraweek range on the $9.50 Calls ended up being from .37 to 1.81 for a gain of 389%, while the $10’s breached the ten-bagger mark with an extraordinary run of 1025% from .12-1.35. Even readers who just caught Friday morning’s mention of these plays could still have made single-session profits of up to 103% and 202%, respectively.

Extended Watchlist:
SNCR, ECYT, MNKD, KTOV, ITUS, RIGL, SRAX, JAGX

Blue Horseshoe Stocks: BBRY Recap, AEMD & More

Blackberry Ltd. BBRY – Options Review

We were very confident in the options ideas we formulated for BBRY in yesterday’s premarket report, which were the BBRY Weekly $9.50 & $10 Calls. We pointed to the company’s convincing earnings beat as being the reason we felt a solid move was in order, despite the fact that it had just been hanging around the $9 area without a lot of volatility for the preceding few weeks.

A solid move is exactly what we got, with BBRY stock running from 9.78 to 10.83 on the day. That facilitated some fantastic gain opportunities for anyone who was following along with our ideas, which both produced multi-bag intraday upswings.

The $9.50 Calls traded in a range from .37-1.26 for a gain of 240%, while the $10’s ripped extremely hard from a low of .12 all the way up to .76. That worked out to an increase of 533% marking the second consecutive week where we’ve alerted on an options idea and seen a single-session gain of over 500% (KMX, last Friday).

Important Note: Never trade options with a weekly expiration on a Friday unless you’re an expert trader with disposable funds. It’s extremely risky.

Aethlon Medical, Inc. AEMD

The other top performer from yesterday’s premarket newsletter was AEMD, which, as you can see from the included chart snapshot, we alerted at the absolute perfect time. The stock had practically been in free-fall over the past couple of weeks, and we signaled the bottom with precision.

It traded in a range from 1.18 to 1.70, for a respectable intraday increase of 44% and closed at the high of day. This is a stock that was trading at nearly $4 just this month, and now we’re going to be monitoring to see how much of that ground it can recapture on the rebound. We’ll look for it to establish higher highs and higher lows. If it can manage to crack through the channel between the current 50DMA of 1.75 and September 11th’s swing high of 2.00, things could once again get very interesting for AEMD.

Extended Watchlist:
HMNY, VERI, ADHD, CONN, ZYNE, VKTX, DOLV

Blue Horseshoe Stocks: AAPL Review & More

Apple, Inc. AAPL – Options Review

We’re now mentioning the calls we made for the Apple options chain on Tuesday for the third consecutive day, after each of our tracked contracts yet again set new highs during yesterday’s session.

To refresh your memory, we slated the AAPL Weekly $150-155 Calls for observation in Tuesday’s premarket report, and they provided solid gain opportunities ranging from 78-146% that day.

Here are the updated figures showing the lows from Tuesday, to the new highs attained yesterday.

$150 Calls – Range: 2.30-4.80 – Max Gain: 109%
$152.50 Calls – Range: 1.00-2.55 – Max Gain: 155%.
$155 Calls – Range: .28-.89 – Max Gain: 218%

Fresh Options Ideas

While we’re on roll with options calls, we might as well let it ride by selecting a couple of other ideas that are worth monitoring.

Tiffany & Co. TIF – Tiffany’s chart is showing a decent bottom setup, while some insider buying was reported this week near 4-month lows. We’re going to highlight the TIF 10/20 $92-93 Calls and keep them on our radars in the days and weeks ahead.

Blackberry Ltd. BBRY – For a more short-term idea, we’re going to signal the BBRY Weekly $9.50 & $10 Calls on the heels of Blackberry’s premarket earning beat. Prior to today, the stock has hovering around a solid level of support at roughly $9 for quite some time, but today’s release could definitely have a positive effect on the chart. The company posted a beat on profits and revenue, while software sales set company records.

Extended Watchlist:
ZYNE, ADHD, IZEA, CHFS, AQMS, GALE, OPGN, AEMD, VTGN